ARTICLE | Clinical News
ACT 1: Phase II data
October 20, 2014 7:00 AM UTC
An Indian Phase II trial in patients with chronic venous leg ulcers showed that topical Granexin gel plus standard of care (SOC) significantly reduced mean percent ulcer area from baseline to week 12 ...